{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T06:35:56Z","timestamp":1775284556070,"version":"3.50.1"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T00:00:00Z","timestamp":1711670400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.bcp.2024.116184","type":"journal-article","created":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T01:45:54Z","timestamp":1711763154000},"page":"116184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Intranasal delivery of paroxetine: A preclinical study on pharmacokinetics, depressive-like behaviour, and neurochemical sex differences"],"prefix":"10.1016","volume":"223","author":[{"given":"Soraia","family":"Silva","sequence":"first","affiliation":[]},{"given":"Joana","family":"Bicker","sequence":"additional","affiliation":[]},{"given":"S.","family":"Fialho","sequence":"additional","affiliation":[]},{"given":"Susana","family":"Cunha","sequence":"additional","affiliation":[]},{"given":"Am\u00edlcar","family":"Falc\u00e3o","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6981-6639","authenticated-orcid":false,"given":"Ana","family":"Fortuna","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2024.116184_b0005","series-title":"Depression and other common mental Disorders: Global Health estimates","author":"WHO","year":"2017"},{"issue":"4","key":"10.1016\/j.bcp.2024.116184_b0010","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1503\/jpn.150205","article-title":"Why is depression more prevalent in women?","volume":"40","author":"Albert","year":"2015","journal-title":"J Psychiatry Neurosci"},{"issue":"1","key":"10.1016\/j.bcp.2024.116184_b0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/pcn.12604","article-title":"Neural basis of major depressive disorder: beyond monoamine hypothesis","volume":"72","author":"Boku","year":"2018","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.bcp.2024.116184_b0020","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1146\/annurev.clinpsy.1.102803.143938","article-title":"Stress and depression","volume":"1","author":"Hammen","year":"2005","journal-title":"Annu. Rev. Clin. Psychol."},{"issue":"6","key":"10.1016\/j.bcp.2024.116184_b0025","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1159\/000506484","article-title":"Alterations of the HPA Axis observed in patients with major depressive Disorder and their relation to Early life stress: a systematic review","volume":"79","author":"Ceruso","year":"2020","journal-title":"Neuropsychobiology"},{"issue":"43","key":"10.1016\/j.bcp.2024.116184_b0030","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2113852118","article-title":"Serotonin modulates melatonin synthesis as an autocrine neurotransmitter in the pineal gland","volume":"118","author":"Lee","year":"2021","journal-title":"PNAS"},{"issue":"1","key":"10.1016\/j.bcp.2024.116184_b0035","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in sTAR* D: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"11","key":"10.1016\/j.bcp.2024.116184_b0040","doi-asserted-by":"crossref","first-page":"e1352","DOI":"10.1016\/S2214-109X(20)30432-0","article-title":"Mental health matters","volume":"8","author":"The Lancet Global","year":"2020","journal-title":"Lancet Glob Health"},{"issue":"4","key":"10.1016\/j.bcp.2024.116184_b0045","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/npp.2008.148","article-title":"Evidence why Paroxetine dose escalation is not effective in major depressive Disorder: a randomized controlled trial with assessment of serotonin transporter occupancy","volume":"34","author":"Ruh\u00e9","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bcp.2024.116184_b0050","article-title":"Optimal dose regimen for paroxetine","volume":"53","author":"Dunner","year":"1992","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.bcp.2024.116184_b0055","article-title":"Pharmacokinetics of immediate and sustained-release formulations of paroxetine: population pharmacokinetic approach to guide paroxetine personalized therapy in chinese psychotic patients","volume":"13","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2024.116184_b0060","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/sj.npp.1300960","article-title":"Multiple dose pharmacokinetics of paroxetine in children and adolescents with major depressive disorder or obsessive-compulsive disorder","volume":"31","author":"Findling","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"10.1016\/j.bcp.2024.116184_b0065","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S0006-3223(03)00074-X","article-title":"Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) P-glycoprotein gene disruption","volume":"54","author":"Uhr","year":"2003","journal-title":"Biol. Psychiatry"},{"issue":"Suppl 1","key":"10.1016\/j.bcp.2024.116184_b0070","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1055\/s-2007-1002354","article-title":"Paroxetin: pharmakokinetik und Pharmakodynamik [Paroxetine: pharmacokinetics and pharmacodynamics]","volume":"62","author":"Hiemke","year":"1994","journal-title":"Fortschr. Neurol. Psychiatr."},{"issue":"12","key":"10.1016\/j.bcp.2024.116184_b0075","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1124\/dmd.114.059576","article-title":"Paroxetine markedly increases plasma concentrations of ophthalmic timolol; CYP2D6 inhibitors may increase the risk of cardiovascular adverse effects of 0.5% timolol eye drops","volume":"42","author":"Maenpaa","year":"2014","journal-title":"Drug Metab. Dispos."},{"issue":"1","key":"10.1016\/j.bcp.2024.116184_b0080","first-page":"77","article-title":"Paroxetine\u2014The antidepressant from hell? probably not, but caution required","volume":"46","author":"Nevels","year":"2016","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.bcp.2024.116184_b0085","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41578-021-00394-w","article-title":"Drug delivery to the central nervous system","volume":"7","author":"Nance","year":"2022","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.bcp.2024.116184_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.120161","article-title":"A combo-strategy to improve brain delivery of antiepileptic drugs: focus on BCRP and intranasal administration","volume":"593","author":"Gon\u00e7alves","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bcp.2024.116184_b0095","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.751321","article-title":"Encapsulated escitalopram and Paroxetine intranasal co-administration. In vitro\/in vivo evaluation","volume":"12","author":"Silva","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116184_b0100","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ijpharm.2019.04.047","article-title":"Nose-to-brain delivery of levetiracetam after intranasal administration to mice","volume":"564","author":"Gon\u00e7alves","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.bcp.2024.116184_b0105","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s11095-020-02786-z","article-title":"Pre-clinical assessment of the nose-to-brain delivery of zonisamide after intranasal administration","volume":"37","author":"Goncalves","year":"2020","journal-title":"Pharm. Res."},{"key":"10.1016\/j.bcp.2024.116184_b0110","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejpb.2020.04.011","article-title":"QbD-driven development of intranasal lipid nanoparticles for depression treatment","volume":"153","author":"Vitorino","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"4","key":"10.1016\/j.bcp.2024.116184_b0115","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s13346-020-00891-5","article-title":"Intranasal drug delivery: opportunities and toxicologic challenges during drug development","volume":"12","author":"Keller","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"issue":"6","key":"10.1016\/j.bcp.2024.116184_b0120","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1517\/14740330802423168","article-title":"Paroxetine: safety and tolerability issues","volume":"7","author":"Marks","year":"2008","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.bcp.2024.116184_b0125","doi-asserted-by":"crossref","first-page":"974","DOI":"10.3389\/fpsyt.2019.00974","article-title":"Cortisol and major depressive Disorder-translating findings from humans to animal models and Back","volume":"10","author":"Nandam","year":"2019","journal-title":"Front. Psych."},{"key":"10.1016\/j.bcp.2024.116184_b0130","article-title":"The unpredictable chronic mild stress protocol for inducing anhedonia in mice","volume":"140","author":"Burstein","year":"2018","journal-title":"J. Vis. Exp."},{"issue":"11","key":"10.1016\/j.bcp.2024.116184_b0135","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s00702-019-02084-y","article-title":"Animal models of major depression: drawbacks and challenges","volume":"126","author":"Planchez","year":"2019","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.bcp.2024.116184_b0140","article-title":"An unpredictable chronic mild stress protocol for instigating depressive symptoms, behavioral changes and negative health outcomes in rodents","volume":"106","author":"Frisbee","year":"2015","journal-title":"J. Vis. Exp."},{"issue":"12","key":"10.1016\/j.bcp.2024.116184_b0145","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1124\/dmd.117.077883","article-title":"Elucidation of the impact of P-glycoprotein and breast cancer resistance protein on the brain distribution of catechol-O-Methyltransferase inhibitors","volume":"45","author":"Bicker","year":"2017","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bcp.2024.116184_b0150","first-page":"127","article-title":"Pharmacokinetic concepts in brain","volume":"10","author":"Hammarlund-Udenaes","year":"2014","journal-title":"Drug Deliv."},{"key":"10.1016\/j.bcp.2024.116184_b0155","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jpba.2012.11.018","article-title":"A mass balance approach for calculation of recovery and binding enables the use of ultrafiltration as a rapid method for measurement of plasma protein binding for even highly lipophilic compounds","volume":"75","author":"Wang","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"1","key":"10.1016\/j.bcp.2024.116184_b0160","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1080\/10717544.2017.1357148","article-title":"Agomelatine-based in situ gels for brain targeting via the nasal route: statistical optimization, in vitro, and in vivo evaluation","volume":"24","author":"Fatouh","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.bcp.2024.116184_b0165","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1007\/s11095-014-1319-1","article-title":"Mechanistic understanding of brain drug disposition to optimize the selection of potential neurotherapeutics in drug discovery","volume":"31","author":"Loryan","year":"2014","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.bcp.2024.116184_b0170","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1124\/dmd.110.035998","article-title":"Measurement of unbound drug exposure in brain: modeling of pH Partitioning explains diverging results between the brain slice and brain homogenate methods","volume":"39","author":"Frid\u00e9n","year":"2011","journal-title":"Drug Metab. Dispos."},{"issue":"7","key":"10.1016\/j.bcp.2024.116184_b0175","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1038\/s41596-018-0011-z","article-title":"Sucrose preference test for measurement of stress-induced anhedonia in mice","volume":"13","author":"Liu","year":"2018","journal-title":"Nat. Protoc."},{"issue":"2","key":"10.1016\/j.bcp.2024.116184_b0180","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/9780470942390.mo110176","article-title":"Depression-related behavioral tests","volume":"2","author":"Powell","year":"2012","journal-title":"Curr Protoc Mouse Biol"},{"key":"10.1016\/j.bcp.2024.116184_b0185","unstructured":"Wishart DS, F.Y., Guo AC, Lo EJ, Marcu A, Grant JR, Sajed T, Johnson D, Li C, Sayeeda Z, Assempour N, Iynkkaran I, Liu Y, Maciejewski A, Gale N, Wilson A, Chin L, Cummings R, Le D, Pon A, Knox C, Wilson M. DrugBank 5.0: a major update to the DrugBank database for 2018. Access Date: 13.09.2023; Available from: https:\/\/go.drugbank.com\/drugs\/."},{"issue":"11","key":"10.1016\/j.bcp.2024.116184_b0190","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/cpdd.948","article-title":"Impact of Paroxetine, a strong CYP2D6 inhibitor, on SPN-812 (viloxazine extended-release) Pharmacokinetics in healthy adults","volume":"10","author":"Wang","year":"2021","journal-title":"Clin. Pharmacol. Drug Dev."},{"issue":"1","key":"10.1016\/j.bcp.2024.116184_b0195","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/009127000004000108","article-title":"CYP2D6 inhibition by fluoxetine, Paroxetine, sertraline, and venlafaxine in a crossover study: intraindividual Variability and plasma concentration Correlations","volume":"40","author":"Alfaro","year":"2013","journal-title":"J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2024.116184_b0200","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/jcpt.12042","article-title":"Dynamics and persistence of CYP2D6 inhibition by paroxetine","volume":"38","author":"Jurica","year":"2013","journal-title":"J. Clin. Pharm. Ther."},{"issue":"2","key":"10.1016\/j.bcp.2024.116184_b0205","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s40262-015-0310-2","article-title":"Reliability of in vitro and in vivo methods for predicting the effect of P-glycoprotein on the delivery of antidepressants to the brain","volume":"55","author":"Zheng","year":"2016","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.bcp.2024.116184_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.resp.2021.103823","article-title":"The role of normal nasal morphological variations from race and gender differences on respiratory physiology","volume":"297","author":"Shah","year":"2022","journal-title":"Respir. Physiol. Neurobiol."},{"issue":"2","key":"10.1016\/j.bcp.2024.116184_b0215","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/toxsci\/kfr240","article-title":"Tissue distribution and gender-divergent expression of 78 cytochrome P450 mRNAs in mice","volume":"124","author":"Renaud","year":"2011","journal-title":"Toxicol. Sci."},{"issue":"6","key":"10.1016\/j.bcp.2024.116184_b0220","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.3390\/ijms22062860","article-title":"Sex-related differences in regional blood-brain Barrier integrity in non-demented elderly subjects","volume":"22","author":"Moon","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2024.116184_b0225","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ynstr.2016.08.002","article-title":"The chronic mild stress (CMS) model of depression: history, evaluation and usage","volume":"6","author":"Willner","year":"2017","journal-title":"Neurobiol. Stress"},{"issue":"1\u20133","key":"10.1016\/j.bcp.2024.116184_b0230","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejphar.2011.10.002","article-title":"Differences between mice strains in response to paroxetine in the forced swimming test: involvement of serotonergic or noradrenergic systems","volume":"672","author":"Sugimoto","year":"2011","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2024.116184_b0235","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/mp.2017.237","article-title":"Differential effects of chronic stress in young-adult and old female mice: cognitive-behavioral manifestations and neurobiological correlates","volume":"23","author":"Lotan","year":"2018","journal-title":"Mol. Psychiatry"},{"issue":"4","key":"10.1016\/j.bcp.2024.116184_b0240","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3803\/EnM.2013.28.4.288","article-title":"Effects of chronic restraint stress on body weight, food intake, and hypothalamic gene expressions in mice","volume":"28","author":"Jeong","year":"2013","journal-title":"Endocrinol. Metab. (Seoul)"},{"issue":"6","key":"10.1016\/j.bcp.2024.116184_b0245","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.oooo.2021.08.015","article-title":"Anticholinergic medication: related dry mouth and effects on the salivary glands","volume":"132","author":"Arany","year":"2021","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"11","key":"10.1016\/j.bcp.2024.116184_b0250","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.euroneuro.2007.03.001","article-title":"Repeated paroxetine treatment reverses anhedonia induced in rats by chronic mild stress or dexamethasone","volume":"17","author":"Casarotto","year":"2007","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"11","key":"10.1016\/j.bcp.2024.116184_b0255","doi-asserted-by":"crossref","first-page":"863","DOI":"10.4088\/JCP.v61n1109","article-title":"Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment","volume":"61","author":"Fava","year":"2000","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.bcp.2024.116184_b0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-007-1035-1","article-title":"Long-lasting behavioral effects and recognition memory deficit induced by chronic mild stress in mice: effect of antidepressant treatment","volume":"199","author":"Elizalde","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"issue":"9","key":"10.1016\/j.bcp.2024.116184_b0265","doi-asserted-by":"crossref","DOI":"10.3390\/cells8091021","article-title":"Deficiency in androgen receptor aggravates the depressive-like behaviors in chronic mild stress model of depression","volume":"8","author":"Hung","year":"2019","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.bcp.2024.116184_b0270","doi-asserted-by":"crossref","first-page":"e71694","DOI":"10.1371\/journal.pone.0071694","article-title":"Visualising androgen receptor activity in male and female mice","volume":"8","author":"Dart","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bcp.2024.116184_b0280","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s41467-021-27604-x","article-title":"Vascular and blood-brain barrier-related changes underlie stress responses and resilience in female mice and depression in human tissue","volume":"13","author":"Dion-Albert","year":"2022","journal-title":"Nat. Commun."},{"issue":"21","key":"10.1016\/j.bcp.2024.116184_b0285","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10215204","article-title":"Cortisol as a Biomarker of mental Disorder severity","volume":"10","author":"Dziurkowska","year":"2021","journal-title":"J. Clin. Med."},{"issue":"6","key":"10.1016\/j.bcp.2024.116184_b0290","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/mp.2012.144","article-title":"Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression","volume":"18","author":"Lamers","year":"2013","journal-title":"Mol. Psychiatry"},{"issue":"9","key":"10.1016\/j.bcp.2024.116184_b0295","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.euroneuro.2011.03.002","article-title":"Antidepressant use and salivary cortisol in depressive and anxiety disorders","volume":"21","author":"Manthey","year":"2011","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.bcp.2024.116184_b0300","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.pscychresns.2019.05.004","article-title":"Pineal gland abnormality in major depressive disorder","volume":"289","author":"Zhao","year":"2019","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"10.1016\/j.bcp.2024.116184_b0305","doi-asserted-by":"crossref","DOI":"10.1100\/2012\/640389","article-title":"Neurobiology, pathophysiology, and treatment of melatonin deficiency and dysfunction","volume":"2012","author":"Hardeland","year":"2012","journal-title":"Scientific World Journal"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224001679?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224001679?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T00:24:10Z","timestamp":1728951850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295224001679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":60,"alternative-id":["S0006295224001679"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116184","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal delivery of paroxetine: A preclinical study on pharmacokinetics, depressive-like behaviour, and neurochemical sex differences","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116184","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116184"}}